Objectification of the stratification criteria in children with appendicular peritonitis for the selective hemoperfusion using the hemosorbent «Hemo-proteazsorb»
DOI:
https://doi.org/10.15574/PS.2021.73.44Keywords:
acute appendicitis, peritonitis, children, extracorporeal hemocorrection, hemoperfusionAbstract
Peritonitis treatment in children remains one of the most complicated and urgent problem of modern surgery and intensive care. Particular attention is paid to therapy aimed to remove proinflammatory mediators and toxic substances. Hemoperfusion (HP) is a method based on elimination of toxic substances of an endogenous or exogenous nature from the patient’s blood by extracorporeal perfusion of whole blood through a special sorbent. However, to date, there are no clear clinical and laboratory criteria for the initiation, prolongation or completion of the HP procedure.
Purpose – to objectify the stratification criteria in children with appendicular peritonitis for the selective HP using the hemosorbent «Hemo-proteazsorb».
Materials and methods. The retrospective analysis of data from 60 patients with appendicular peritonitis was provided. Discriminant analysis was used.
Results. Stratification criteria based on clinical and laboratory parameters of patients have been developed for HF procedure.
Conclusions. The proposed scheme allows to stratify patients with appendicular peritonitis for the HP procedure. It makes possible to control the results of HP manipulation and allows to make decision whether to continue or complete treatment using the HP. Considering different capabilities of medical institutions, we recommend using the proposed method after validation of the results in these institutions.
The study was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee. The informed consent of the parents for the research was obtained.
No conflict of interest was declared by the authors.
References
Afanas'eva OI, Voinov VA, Gol'dfarb YS. (2016). Ekstrakorporal'naya gemokorrekciya: terminologiya, yazykovye sootvetstviya. Nekommercheskoe partnerstvo «Natsionalnoe obschestvo spetsialistov v oblasti gemafereza i ekstrakorporalnoy gemokorrektsii». Moskva. Sankt-Peterburg. IMZH-SPB: 36.
Chang T, Tu YK, Lee CT, Chao A, Huang CH, Wang MJ et al. (2017). Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis. Crit Care Med. 45 (8): e858-64. https://doi.org/10.1097/CCM.0000000000002362; PMid:28445237 PMCid:PMC5515642
Cruz DN, Antonelli M, Fumagalli R et al. (2009). Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 301: 2445-2452. https://doi.org/10.1001/jama.2009.856; PMid:19531784
CytoSorb. (2021). The adsorber. URL: https://cytosorb-therapy.com/en/the-adsorber/.
Gruda MC, Ruggeberg KG, O'Sullivan P, Guliashvili T, Scheirer AR, Golobish TD et al. (2018). Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb sorbent porous polymer beads. PLoS One. 13 (1): e0191676. https://doi.org/10.1371/journal.pone.0191676; PMid:29370247 PMCid:PMC5784931
Houschyar KS, Pyles MN, Rein S, Nietzschmann I, Duscher D, Maan ZN et al. (2017). Continuous hemoadsorption with a cytokine adsorber during sepsis - a review of the literature. Int J Artif Organs. 40 (5): 205-211. https://doi.org/10.5301/ijao.5000591; PMid:28525674
Kase Y, Obata T, Okamoto Y, Iwai K, Saito K, Yokoyama K, Takinami M, Tanifuji Y. (2008). Removal of 2 arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock. Ther. Aphe r. 1 2 (5): 374-380. https://doi.org/10.1111/j.1744-9987.2008.00612.x; PMid:18937720
Khilnani P, Deopujari S, Carcillo J. (2008). Recent advances in sepsis and septic shock. Indian J Pediatr. 75: 821. https://doi.org/10.1007/s12098-008-0154-y; PMid:18769894
Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. (2018). Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med. 44 (12): 2205-2212. https://doi.org/10.1007/s00134-018-5463-7; PMid:30470853 PMCid:PMC6280819
Kogelmann K, Jarczak D, Scheller M, Druner M. (2017). Hemoadsorption by CytoSorb in septic patients: a case series. Crit Care. 21 (1): 74. https://doi.org/10.1186/s13054-017-1662-9; PMid:28343448 PMCid:PMC5366999
Malard B, Lambert C, Kellum JA. (2018). In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp. 6 (1): 12. https://doi.org/10.1186/s40635-018-0177-2; PMid:29728790 PMCid:PMC5935601
Milliken I, Fitzpatrick M, Subramaniam R. (2006). Single-port laparoscopic insertion of peritoneal dialysis catheters in children. J Pediatr Urol. 2 (4): 308-311. https://doi.org/10.1016/j.jpurol.2005.10.012; PMid:18947627
Payen D. (2019). Haemoperfusion with polymyxin B membrane: recent results for an old debate. Anaesth Crit Care Pain Med. 38 (1): 3-4. https://doi.org/10.1016/j.accpm.2018.12.010; PMid:30635098
Payen DM, Guilhot J, Launey Y et al. (2015). Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 41: 975-984. https://doi.org/10.1007/s00134-015-3751-z; PMid:25862039 PMCid:PMC4477725
Poli EC, Rimmele T, Schneider AG. (2019). Hemoadsorption with CytoSorb. Intensive Care Med. 45 (2): 236-239. https://doi.org/10.1007/s00134-018-5464-6; PMid:30446798
Reinhart K, Meier-Hellmann A. (2005). Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis. Crit Care Med. 33 (2): 461-462. https://doi.org/10.1097/01.CCM.0000132902.54925.B5; PMid:15286541
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R et al. (2017). Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 43 (3): 304-377. https://doi.org/10.1007/s00134-017-4683-6; PMid:28101605
Ronco C, Brendolan A, Dan M et al. (2000). Adsorption in sepsis. Kidney Int. Suppl. 76: 148-155. https://doi.org/10.1046/j.1523-1755.2000.07619.x; PMid:10936812
Sarnackaya VV, Snezhkova EA, Maslenyj VN, Sidorenko AS, YUshko LA. (2014). Kratkoe nastavlenie po sovremennoj taktike primeneniya gemosorbcionnogo metoda v klinicheskoj praktike. Institut eksperimental'noj patologii, onkologii i radiobiologii im. R. E. Kaveckogo NAN Ukrainy: 29. URL: https://dializ.ru/dializ/doc/hemosorbtion-book-web.pdf.
Schadler D, Pausch C, Heise D, Meier-Hellmann A, Brederlau J, Weiler N et al. (2017). The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial. PLoS One. 12 (10): e0187015. https://doi.org/10.1371/journal.pone.0187015; PMid:29084247 PMCid:PMC5662220
Shoji H. (2007). Extracorporeal Endotoxin Removal for the Treatment of Sepsis: Endotoxin Adsorption Cartridge (Toraymyxin). Therapeutic Apheresis and Dialysis. 1: 108-114. https://doi.org/10.1046/j.1526-0968.2003.00005.x; PMid:12921125
Yaroustovsky MB, Gelfand B, Popok Z, Abramyan M, Nazarova E, Yakovleva I, Popov DA, Plyushtch M. (2008). Lipopolysaccharide adsorption in combined therapy of patients with severe sepsis. Crit Care. 12 (2): 178. https://doi.org/10.1186/cc6676; PMCid:PMC4088826
Yarustovskij MB. (2008). Sovremennye metody ekstrakorporal'noj terapii v kompleksnom lechenii sepsisa. Intensivnaya terapiya. 17 (1): 3-6.
Yаkubcevich RE, Spas VV, Shapel IA, Kuznecov OE. (2008). Vozmozhnosti eliminacii vospalitel'nyh mediatorov pri sepsise s pomoshch'yu sorbcionnyh metodov detoksikacii. Anesteziologiya i reanimatologiya. Moskva: Meditsina. 6: 55-57.
Zhang L, Feng Y, Fu P. (2021). Blood purification for sepsis: an overview. Precision Clinical Medicine. 4 (1): 45-55. https://doi.org/10.1093/pcmedi/pbab005
Downloads
Published
Issue
Section
License
The policy of the Journal “PAEDIATRIC SURGERY. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license(СС BY-NC).
Authors transfer the copyright to the Journal “PAEDIATRIC SURGERY.UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
